BioPharma

19 October, 2026 | Monday | News

How Long It Takes to Start a Clinical Trial in 8 APAC Markets, Timed

If you are building a 2027 trial budget this month, you are probably working from a spreadsheet with one row per country and a column headed "start-up". Most of the numbers in that column trace back to one of t...

Lab

20 October, 2026 | Tuesday | News

HistoIndex and A*STAR Partner to Accelerate Fibrosis Drug Development Through AI-Powered Digital Pathology

HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memora...

BioTech

15 October, 2026 | Thursday | News

China’s Hiteck Biological Pharma Licenses Next-Generation Eye Therapy to Visara for Global Development

Wuhan Hiteck Biological Pharma Co., Ltd.  announced that it has entered into an exclusive license agreement (the "License Agreement") with Visara, Inc. ("Visara"), a majority-owned ophthalmology subsidiary...

Contract Services

14 October, 2026 | Wednesday | News

360biolabs Expands Australian Footprint with New Bioanalytical Laboratory in Sydney

  The new 360biolabs facility in North Ryde is strategically located within one of Sydney’s vibrant science and medtech hubs, Macquarie Park Innovation District alongside a growing community of inno...

Consumer Health

15 October, 2026 | Thursday | News

Roche Secures Global Rights to Rona Therapeutics’ RNAi Obesity Candidate in Deal Worth Up to $1.16 Billion

- Rona Therapeutics announced it has granted Roche an exclusive worldwide license for Rona's investigational RNAi candidate targeting activin receptor-like kinase 7 (ALK7) utilizing the company's proprietary ex...

Medtech

20 October, 2026 | Tuesday | News

Helfie AI Partners With Health Innovation South West to Advance Smartphone-Based Hypertension Screening

Helfie AI and UK-based Health Innovation South West have announced a partnership to explore how digital-first approaches to hypertension screening can support earlier identification of people at risk of high bl...

Cell & Gene

16 October, 2026 | Friday | News

NueCell Bio Joins CIRM Partnership to Accelerate Cell and Gene Therapies from Discovery to GMP Readiness

NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced it has joined the Industry Resource Partnership (IRP) Program of the Cali...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close